ECM proteases generally showed a widespread negative correlation with PEBP1/STK11 co-expression across all cancer types, with the exception of MMP15 and SPG7, which displayed positive correlations in most of the cancers analyzed. This evidence concerns the gene PEBP1 and cancer.